1 Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
2 Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005; 429(5):1208-1236.
3 European Association For The Study Of The Liver, European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol.2012;56:908-943.
4 Roayaie S, Jibara G, Tabrizian P, Park JW, Yang J, Yan L, Schwartz M, Han G, Izzo F, Chen M, Blanc JF, Johnson P, Kudo M, Roberts LR, Sherman M. The role of hepatic resection in the treatment of hepatocellular cancer. Hepatology. 2015;62(2):440-451.
5 Capussotti L, Ferrero A, Viganò L, Muratore A, Polastri R, Bouzari H. Portal hypertension: contraindication to liver surgery? World J Surg. 2006;30(6):992-999.
6 Kawano Y, Sasaki A, Kai S, Endo Y, Iwaki K, Uchida H, Shibata K, Ohta M, Kitano S. Short and long-term outcomes after hepatic resection for hepatocellular carcinoma withconcomitant esophageal varices in patients with cirrhosis. Ann Surg Oncol. 2008;15(6):1670-1676.
7 Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg.2006; 243(3): 321–328.
8 Zhou J, Sun HC, Wang Z, Cong WM, Wang JH, Zeng MS, Yang JM, Bie P, Liu LX, Wen TF, Han GH, Wang MQ, Liu RB, Lu LG, Ren ZG, Chen MS, Zeng ZC, Liang P, Liang CH, Chen M, Yan FH, Wang WP, Ji Y, Cheng WW, Dai CL, Jia WD, Li YM, Li YX, Liang J, Liu TS, Lv GY, Mao YL, Ren WX, Shi HC, Wang WT, Wang XY, Xing BC, Xu JM, Yang JY, Yang YF, Ye SL, Yin ZY, Zhang BH, Zhang SJ, Zhou WP, Zhu JY, Liu R, Shi YH, Xiao YS, Dai Z, Teng GJ, Cai JQ, Wang WL, Dong JH, Li Q, Shen F, Qin SK, Fan J. Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition). Liver Cancer. 2018;7(3):235-260.
9 Coskun M. Hepatocellular Carcinoma in the Cirrhotic Liver: Evaluation Using Computed Tomography and Magnetic Resonance Imaging. Exp Clin Transplant. 2017;15(Suppl 2):36-44.
10 Kerdsuknirun J, Vilaichone V, Vilaichone RK. Clinical Outcome and Predictive Factors of Variceal Bleeding in Patients with Hepatocellular Carcinoma in Thailand. Asian Pac J Cancer Prev. 2018;19(11):3301-3305.
11 Su AP, Zhang ZD, Tian BL, Zhu JQ. Transjugular intrahepatic portosystemic shunt versus open splenectomy and esophagogastric devascularization for portal hypertension with recurrent variceal bleeding. Hepatobiliary Pancreat Dis Int. 2017;16(2):169-175.
12 Lin J, Liu Q, Liang Z, He W, Chen J, Ma J, Gu C, Wang W. Laparoscopic selective esophagogastric devascularization and splenectomy for patients with cirrhotic portal hypertension. Wideochir Inne Tech Maloinwazyjne. 2019;14(2):187-194.
13 Chen XP, Wu ZD, Huang ZY, Qiu FZ. Use of hepatectomy and
splenectomy to treat hepatocellular carcinoma with cirrhotic
hypersplenism. Br J Surg 2005; 92(3): 334–339.
14 Li W, Shen SQ, Wu SM, Chen ZB, Hu C, Yan RC. Simultaneous hepatectomy and splenectomy versus hepatectomy alone for hepatocellular carcinoma complicated by hypersplenism: a meta-analysis. Onco Targets Ther. 2015; 8:2129–2137.
15 Pei Y, Zhang Z, Mba'nbo-Koumpa AA, Chen X, Zhang W. Improved survival following splenectomy combined with curative treatments for hepatocellular carcinoma in Child B patients: A propensity score matching study. Hepatol Res. 2019;49(2):177-188.
16 Bruix J, Sherman M; Practice Guidelines Committee, American Association for the Study of Liver Diseases. Management of hepatocellular carcinoma. Hepatology. 2005;42(5):1208-1236.
17 Sun YW, Chen W, Luo M, Hua R, Liu W, Huo YM, Wu ZY, Cao H. Evaluation of surgical procedure selection based on intraoperative free portal pressure measurement in patients with portal hypertension. Hepatobiliary Pancreat Dis Int. 2010;9(3):269-274.
18 Longci Sun, Hong Zhou, Lei Gu, Chunhui Jiang, Ye Liu, Qing Xu. Effects of surgical procedures on the occurrence and development of postoperative portal vein thrombosis in patients with cirrhosis complicated by portal hypertension. Int J Surg. 2015; 16(ptA):31-35.
19 Yang T, He H, Yuan J, Zhang J, Lu J, Lau WY, Yang G, Shen Y, Wang Z, Alshebeeb K, Wu M, Shen F. Surgery for hepatocellular carcinoma presenting with variceal bleeding: The eastern experience. J Surg Oncol. 2016;113(2):165-174.
20 Zheng S, Sun P, Liu X, Li G, Gong W, Liu J. Efficacy and safety of laparoscopic splenectomy and esophagogastric devascularization for portal hypertension: A single-center experience. Medicine (Baltimore). 2018;97(50): e13703
21 Ferraz AA, Bacelar TS, Silveira MJ, et al. Surgical treatment of schistosomal portal hypertension. Int Surg. 2001;86(1):1-8.
22 Silva Neto WBD, Tredicci TM, Coelho FF, Makdissi FF, Herman P. Portal pressure decrease after esophagogastric devascularization and splenectomy in schistosomia. Arq Gastroenterol. 2018;55(2):170-174.
23 Lacerda CM, Ramos H, Raia S, Kelner S. Fisiopatologia da hipertensão portal esquistossomótica e efeitos da esplenectomia com ligadura de varizes de esôfago. Acta Cir. Bras. 1993; 8:113-117.
24 de Cleva R, Pugliesi V, Silberstein B, Saad WA, Pinotti HW, Laudanna AA. Systemic hemodynamic changes in mansonic schistosomiasis with portal hypertension with portal hypertension treated by azygoportal disconnection and splenectomy. Am J Gastroenterol. 1999; 94:1632-1637.
25 Chen MS, Li JQ, Liang HH, Lin XJ, Guo RP, Zheng Y, Zhang YQ. Comparison of effects of percutaneous radiofrequency ablation and surgical resection on small hepatocellular carcinoma. Zhonghua Yi Xue Za Zhi. 2005;85(2):80-83.
26 Changyong E, Wang D, Yu Y, Liu H, Ren H, Jiang T. Efficacy comparison of radiofrequency ablation and hepatic resection for hepatocellular carcinoma: A meta-analysis. J Cancer Res Ther. 2017;13(4):625-630.
27 Qi X, Zhao Y, Li H, Guo X, Han G. Management of hepatocellular carcinoma: an overview of major findings from meta-analyses. Oncotarget. 2016;7(23):34703-34751.
28 Ng KKC, Chok KSH, Chan ACY, Cheung TT, Wong TCL, Fung JYY, Yuen J, Poon RTP, Fan ST, Lo CM. Randomized clinical trial of hepatic resection versus radiofrequency ablation for early-stage hepatocellular carcinoma. Br J Surg. 2017;104(13):1775-1784.
29 Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, Sugawara Y, Minagawa M, Takayama T, Kawasaki S, Makuuchi M. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38(2):200-207.
30 Wu CJ, Chau GY, Lee IC, Huo TI, Su CW, Hou MC, Huang YH. Early and late recurrence of surgically resected hepatitis B virus-related hepatocellular carcinoma on nucleos(t)ide analogues therapy. J Formos Med Assoc. 2020 Dec 14; S0929-6646(20)30596-9.
31 Lee HW, Lee JM, Yoon JH, Kim YJ, Park JW, Park SJ, Kim SH, Yi NJ, Suh KS. A prospective randomized study comparing radiofrequency ablation and hepatic resection for hepatocellular carcinoma. Ann Surg Treat Res. 2018;94(2):74-82.
32 Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ, Lin XJ, Lau WY. A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg. 2006;243(3):321-328.
33 Zheng S, Sun P, Liu X, Li G, Gong W, Liu J. Efficacy and safety of laparoscopic splenectomy and esophagogastric devascularization for portal hypertension: A single-center experience. Medicine (Baltimore). 2018;97(50): e13703.
34 Su AP, Zhang ZD, Tian BL, Zhu JQ. Transjugular intrahepatic portosystemic shunt versus open splenectomy and esophagogastric devascularization for portal hypertension with recurrent variceal bleeding. Hepatobiliary Pancreat Dis Int. 2017;16(2):169-175.
35 Takamatsu Y, Hori T, Machimoto T, Hata T, Kadokawa Y, Ito T, Kato S, Yasukawa D, Aisu Y, Kimura Y, Kitano T, Yoshimura T. Intentional Modulation of Portal Venous Pressure by Splenectomy Saves the Patient with Liver Failure and Portal Hypertension After Major Hepatectomy: Is Delayed Splenectomy an Acceptable Therapeutic Option for Secondary Portal Hypertension? Am J Case Rep. 2018; 19:137-144.
36 Fujisaki S, Miyake H, Amano S, Nakayama H, Tomita R, Fukuzawa M. Influence of the extent of hepatectomy on the portal hypertensive state in patients with hepatoma. Hepatogastroenterology. 1999;46(28):2490-2494.
37 Terrault NA, Lok ASF, McMahon BJ, Chang KM, Hwang JP, Jonas MM, Brown RS Jr, Bzowej NH, Wong JB. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67(4):1560-1599. Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis. 2003;23(1):47-58.
38 Fattovich G. Natural history and prognosis of hepatitis B. Semin Liver Dis
. 2003;23(1):47-58.
39 Fattovich G, Pantalena M, Zagni I, Realdi G, Schalm SW, Christensen Erik, European Concerted Action on Viral Hepatitis (EUROHEP). Effect of hepatitis B and C virus infection on the natural history of compensated cirrhosis: a cohort study of 297 patients. Am J Gastroenterol.2002;97(11):2886–2895.
40 de Jongh FE, Janssen HL, de Man RA, Hop WC, Schalm SW, van Blankenstein M. Survival and prognostic indicators in hepatitis B surface antigen-positive cirrhosis of the liver. Gastroenterology. 1992;103(5):1630-1635.
41 Fattovich G, Giustina G, Realdi G, Corrocher R, Schalm SW. Long-term outcome of hepatitis B e antigen–positive patients with compensated cirrhosis treated with interferon alfa. Hepatology 1997;26(5):1338–1342.
42 Chinese Society of Infectious Diseases, Chinese Medical Association; Chinese Society of Hepatology, Chinese Medical Association. The guidelines of prevention and treatment for chronic hepatitis B (2019 version). Zhonghua Gan Zang Bing Za Zhi. 2019;20;27(12):938-961.
43 Yin XY, Lai PB, Lee JF, Lau JW. Effects of hepatic blood inflow occlusion on liver regeneration following partial hepatectomy in an experimental model of cirrhosis. Br J Surg. 2000;87(11):1510-1515.